Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2025-10-16 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Regulations, reporting receipt of a show cause notice (SCN) from a tax authority regarding GST issues. It includes details of the notice, penalty amount, and the company's response. The document is a regulatory announcement informing the stock exchanges about a legal/regulatory matter affecting the company. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report but a compliance disclosure under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-16 English
Allotment of ESOP
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the exercise price, and the resulting increase in the company's paid-up equity share capital. There is no financial report, earnings data, or management discussion. The content focuses on a share capital change due to ESOP exercise and allotment. This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues or capital changes. The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Therefore, the correct classification is SHA with high confidence.
2025-10-10 English
Updates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the allotment of equity shares under an Employee Stock Option Plan (ESOP). It details the number of shares allotted, the exercise price, and the resulting increase in the company's paid-up equity share capital. There are no financial statements, quarterly or annual results, or management discussion and analysis. The document is an announcement of a share allotment related to employee stock options, which fits the category of Share Issue/Capital Change. The document length is short and it is not a report or a presentation but a notification of a capital change event.
2025-10-10 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the period ended September 30, 2025. It is addressed to stock exchanges and signed by the Registrar and Share Transfer Agent. The document is short (2888 characters) and serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities and share transfer regulations, fitting best under Regulatory Filings (RNS).
2025-10-07 English
Certificate under Reg. 74 (5)
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details of securities dematerialized/rematerialized for the period ended September 30, 2025. It is addressed to stock exchanges and signed by the company secretary and the registrar. The document is short (2888 characters) and serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance filing related to securities and share transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2025-10-07 English
Copy of Newspaper Publication
Regulatory Filings Classification · 72% confidence The document is a combination of two regulatory notices rather than a financial report or investor presentation. The first half is a stock‐exchange disclosure under SEBI LODR Regulation 30 announcing a newspaper notice of hearing for a Composite Scheme of Amalgamation (an M&A-related announcement). The second half is an e‐auction sale notice under the SARFAESI Act. Neither contains substantive financial statements, earnings highlights, or board changes, nor is it a full merger proxy or tender offer document. These are miscellaneous compliance/regulatory disclosures, so the correct category is Regulatory Filings (RNS).
2025-10-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.